23:26:20 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-11-13 Kvartalsrapport 2024-Q3
2024-08-27 Kvartalsrapport 2024-Q2
2024-05-08 Kvartalsrapport 2024-Q1
2024-05-02 Ordinarie utdelning LIFE 0.00 NOK
2024-04-30 Årsstämma 2024
2024-02-27 Bokslutskommuniké 2023
2023-11-14 Kvartalsrapport 2023-Q3
2023-08-23 Kvartalsrapport 2023-Q2
2023-05-11 Kvartalsrapport 2023-Q1
2023-05-08 Ordinarie utdelning LIFE 0.00 NOK
2023-04-18 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-09 Ordinarie utdelning LIFE 0.00 NOK
2022-05-06 Årsstämma 2022
2022-04-21 Bokslutskommuniké 2021
2021-09-30 Extra Bolagsstämma 2021
2021-08-05 Kvartalsrapport 2021-Q2
2021-05-10 Ordinarie utdelning LIFE 0.00 NOK
2021-05-07 Årsstämma 2021
2021-04-20 Bokslutskommuniké 2020
2020-06-26 Årsstämma 2020
2020-06-01 Bokslutskommuniké 2019
2019-02-07 Split LIFE 4:1
2018-12-11 Extra Bolagsstämma 2018

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
Lifecare är ett norskt bolag verksamma inom medicinteknik. Idag är bolaget specialiserade inom forskning och utveckling av diabetes. Produkterna är patenterade och används som glukosgivare. Mikrosensorerna injiceras under huden på patientens handled, och fungerar vidare som en realtidsuppdatering av glukosnivån i patienten. Utöver bidrar tekniken med larmsensor samt tillgång till historisk data över patientens glukosnivå. Bolaget etablerades under 2006 och har sitt huvudkontor i Bergen, Norge.
2020-09-07 09:00:00
The board of directors of Lifecare has appointed Joacim Holter as CEO for
Lifecare with immidiate effect. Holter have been a member of the Lifecare BoD
since 2011 and was the Chairman of the BoD from 2012 to 2016. 
Holter has solid experience from leading international companies from the R&D
stage to a commercial operation. Since 2015 he as been MD and Chairman of the
Swiss company Osmotex AG (www.osmotex.ch) and prior to this he was practicing as
attorney at law with his own practice in his hometown Bergen. He will combine
his responsibility as MD of Osmotex AG and CEO at Lifecare until further notice.

Holter will step aside as member of Lifecare BoD as soon as an replacement is
appointed at an extraordinary general assembly.  Holter will take seat as the
Lifecare representative in Digital Diagnostics AG, a company Lifecare has a 25%
ownership in. 
“The BoD is very pleased to have found a solution with Joacim Holter as the CEO.
 Our partnership with Digital Diagnostic AG and the next phase with our own
products will require a strong drive, solid negotiation skills in an
international context and ability to execute quickly.  Knowing Lifecare from the
inside, Joacim is well placed to navigate all the opportunities we have ahead of
us, says Christian Hysing Dahl, Chairman of the board of Lifecare.    


*****


For interviews or more information, please contact:

Joacim Holter, CEO
joacim.holter@lifecare.no
tel: +47 40059040